Aprea Therapeutics
APRE
APRE
23 hedge funds and large institutions have $2.39M invested in Aprea Therapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less capital invested
Capital invested by funds: $3.07M → $2.39M (-$685K)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$20.2K | |
| 2 | +$4.08K | |
| 3 | +$2.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.43K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$8 |
Top Sellers
| 1 | -$275K | |
| 2 | -$25.7K | |
| 3 | -$24.6K | |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$22.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.94K |